ArticleCureus2025
Dieulafoy's Lesion: A Rare and Elusive Cause of Massive Upper Gastrointestinal Bleeding Managed With Endoscopic Therapy.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A Dieulafoy's lesion is a rare vascular anomaly that can cause massive upper gastrointestinal bleeding. It often presents with hematemesis and requires prompt diagnosis and intervention. We report a case of a 54-year-old male patient with hypertension and diabetes mellitus who presented to the emergency department with hematemesis. After the initial resuscitation, an esophagogastroduodenoscopy revealed a pulsatile submucosal artery in the proximal stomach, consistent with a Dieulafoy's lesion. No evidence of peptic ulcer disease, gastric varices, or malignancy was noted. Endoscopic hemostasis was achieved using an epinephrine injection followed by thermal coagulation. The patient's hospital course was uncomplicated, with no further bleeding episodes. Computed tomography angiography confirmed the diagnosis and ruled out other potential sources of bleeding. The patient was discharged on a proton pump inhibitor regimen and scheduled for a follow-up endoscopy in six weeks, which showed complete mucosal healing. A Dieulafoy's lesion remains a challenging diagnosis due to its subtle presentation and requires a high index of suspicion, especially in patients with unexplained gastrointestinal bleeding. Endoscopic therapy is highly effective in managing this condition and, when promptly addressed, results in excellent outcomes. This case highlights the importance of early recognition and intervention, contributing to the growing body of evidence supporting the role of endoscopy in the management of Dieulafoy's lesion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.